Compound Profile
Uc II Collagen
Uc Ii Collagen carries a Grade B rating — moderate evidence.
Last reviewed: •2 sources citedReport a correctionProfile-wide ·B Moderate
Use extra caution — Review medications, pregnancy status, chronic conditions, and clinician guidance before use. Details
- Evidence
- Moderate evidence
- Typical onset
- Varies by prep
- Safety rating
- Use extra caution: Interaction risk
- Best for
- Inflammation, Immune Function
Safety
Safety & Cautions
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Interaction-AwareMedication or interaction context is explicitly noted.
- Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
- Safety evidence
- one 180-day trial of a specific undenatured type II collagen product
- Who should avoid this?
- No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
- Talk to a professional if
- you use relevant medications, you are pregnant or breastfeeding.
Safety outcomes did not differ from placebo or glucosamine-chondroitin, but product-source allergy, pregnancy, breastfeeding, autoimmune disease, longer-term use, organ impairment, and medication-interaction safety remain insufficient.
Evidence Summary
Profile-wide ·B ModerateEvidence lens
Useful signal, but study design, dose, and population still matter.
ModerateModerate evidence
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Immune Signaling Modulation · Oral Tolerance Induction · Th2/Treg Skewing (Proposed)
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.
This profile cites 2 human studies.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Uc II Collagen has a moderate evidence rating.
Inflammation SupportLongevity
Citation density
1.0
Sources
2
Effects
2
Research recency
Mixed recency
Evidence Grade
Grade B: Moderate Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Randomized controlled trial
- Risk of Bias
- Low
- Consistency
- Not assessed
Strongest recorded design is a randomized controlled trial, drawn from 2 recorded studies, 2 in people.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (2)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable
What the evidence actually shows
This table contains 2 structured sources, including 0 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Effects of Native Type II Collagen Treatment on Knee Osteoarthritis: A Randomized Controlled Trial PubMed · Eurasian J Med · 2016 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
PubMed · J Int Soc Sports Nutr · 2013 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
How Uc II Collagen Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Uc II Collagen Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Dosing
- No standardized dose
- No standardized dose is established for this ingredient in our source data. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
- Immune Signaling Modulation
- Oral Tolerance Induction
- Th2/Treg Skewing (Proposed)
- Anti Inflammatory Cytokine Modulation
- Inflammatory Signaling Modulation
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Uc II Collagen evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.